North Star Investment Management Corp. Sells 9,405 Shares of CVS Health Co. (NYSE:CVS)

North Star Investment Management Corp. reduced its position in CVS Health Co. (NYSE:CVS - Free Report) by 64.3% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,219 shares of the pharmacy operator's stock after selling 9,405 shares during the period. North Star Investment Management Corp.'s holdings in CVS Health were worth $354,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of CVS. Hopwood Financial Services Inc. acquired a new stake in shares of CVS Health in the 4th quarter worth about $29,000. McIlrath & Eck LLC raised its stake in shares of CVS Health by 32.6% in the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after purchasing an additional 174 shares during the last quarter. Financial Perspectives Inc lifted its holdings in shares of CVS Health by 137.5% in the fourth quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock valued at $36,000 after purchasing an additional 466 shares in the last quarter. Compass Planning Associates Inc bought a new stake in CVS Health during the fourth quarter worth $37,000. Finally, Providence First Trust Co purchased a new stake in CVS Health in the 4th quarter valued at $42,000. Institutional investors own 80.66% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on CVS. Morgan Stanley reissued an "overweight" rating on shares of CVS Health in a research report on Tuesday, April 15th. JPMorgan Chase & Co. boosted their price target on shares of CVS Health from $80.00 to $81.00 and gave the stock an "overweight" rating in a report on Tuesday, February 18th. Mizuho boosted their target price on shares of CVS Health from $70.00 to $76.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Truist Financial upped their price objective on CVS Health from $82.00 to $84.00 and gave the company a "buy" rating in a research note on Monday, May 12th. Finally, Barclays set a $79.00 price objective on CVS Health and gave the stock an "overweight" rating in a report on Monday, June 2nd. Two research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $74.75.

CVS Health Trading Up 0.4%

Shares of CVS Health stock traded up $0.28 during midday trading on Monday, reaching $67.74. 7,575,975 shares of the company's stock traded hands, compared to its average volume of 10,965,143. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81. The stock has a 50 day moving average of $65.15 and a 200-day moving average of $60.15. The company has a market cap of $85.69 billion, a PE ratio of 18.51, a price-to-earnings-growth ratio of 0.98 and a beta of 0.56. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $72.51.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, beating the consensus estimate of $1.62 by $0.63. The business had revenue of $94.59 billion during the quarter, compared to analyst estimates of $93.07 billion. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. The company's revenue for the quarter was up 7.0% on a year-over-year basis. During the same quarter last year, the firm posted $1.31 earnings per share. As a group, equities analysts expect that CVS Health Co. will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd were issued a $0.665 dividend. The ex-dividend date of this dividend was Tuesday, April 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 3.93%. CVS Health's payout ratio is currently 63.48%.

Insiders Place Their Bets

In other news, Director Guy P. Sansone purchased 1,570 shares of the company's stock in a transaction on Thursday, June 5th. The stock was acquired at an average cost of $63.70 per share, for a total transaction of $100,009.00. Following the completion of the transaction, the director now directly owns 12,007 shares in the company, valued at $764,845.90. This trade represents a 15.04% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. 1.22% of the stock is owned by insiders.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.